Arcadia Biosciences (RKDA) Receivables - Net (2016 - 2025)
Arcadia Biosciences' Receivables - Net history spans 12 years, with the latest figure at $425000.0 for Q4 2025.
- For Q4 2025, Receivables - Net fell 63.83% year-over-year to $425000.0; the TTM value through Dec 2025 reached $425000.0, down 63.83%, while the annual FY2025 figure was $425000.0, 63.83% down from the prior year.
- Receivables - Net reached $425000.0 in Q4 2025 per RKDA's latest filing, down from $831000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $3.9 million in Q2 2022 to a low of $304000.0 in Q3 2023.
- Average Receivables - Net over 5 years is $1.3 million, with a median of $1.1 million recorded in 2021.
- Peak YoY movement for Receivables - Net: surged 289.54% in 2021, then plummeted 88.85% in 2023.
- A 5-year view of Receivables - Net shows it stood at $1.4 million in 2021, then decreased by 12.41% to $1.2 million in 2022, then plummeted by 57.83% to $506000.0 in 2023, then surged by 132.21% to $1.2 million in 2024, then crashed by 63.83% to $425000.0 in 2025.
- Per Business Quant, the three most recent readings for RKDA's Receivables - Net are $425000.0 (Q4 2025), $831000.0 (Q3 2025), and $1.3 million (Q2 2025).